Bronchiectasis: A reemerging disease;Bronchiectasies: Une pathologie qui réémerge

Revue Medicale Suisse

Volumn 3, Issue 99, 2007, Pages 477-483

  Frey, Jean Georges ^a  

^a Centre Valaisan de Pneumologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HUMAN; INTENSIVE CARE UNIT; MORAXELLA CATARRHALIS; MORTALITY; MYCOBACTERIUM; PATHOPHYSIOLOGY; PREVALENCE; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

BRONCHIECTASIS; HUMANS; PREVALENCE; SWITZERLAND;

EID: 33947145179     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ** Barker AF. Bronchiectasis. N Engl J Med 2002; 346:1383-91.
2. Reid LM. Reduction in bronchial subdivision in bronchiectasis. Thorax 1950;5:233-47.
3. Singleton P, et al. Bronchiectasis in Alaska Native Children: Causes on clinical outcomes. Pediatr Pulmonol 2000;29:182-7.
4. * Werker JM, et al. Bronchiectasis USA overvall prevalence. Am J Resp Crit Care Med 2004;169:A332.
5. Madadeva R, et al. Clinical and radiological characterictics of lung disease in inflammation bowel disease. Eur Respir J 2000;15:41-8.
6. Camus P, et al. The lung in inflammation bowel disease. Europ Respir J 2000;15:5-10.
7. ** Cohen M, et al. Bronchiectasis in Systemic disease. Chest 1999;116;1063-74.
8. Nicotra ME, et al. Clinical pathophysiologisc an microbiologic characteristics of bronchiectasis in an aging cohort. Chest 1995;108;955-61.
9. Pasteur MC, et al. Bronchiectasis in UK. Am J Respir Crit Care Med 2000;162;1277-84.
10. * Li AM. Non CF bronchiectasis does knowing the aetiology lead to change in management? Europ Resp J 2005;26:8-14.
11. Barker AF, et al. Tobramycin solution for inhalation reduces Sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000;162: 481-5.
12. Cymbala AA, et al. The disease modifying effect of twice weekly oral azythromycin in patients with bronchiectasis. Treat Respir Med 2005;4:117.
13. Elbornet E, et al. Bronchiectasis. Respir Med 1992; 86:121-4.
14. * Tsang KW, et al. Inhaled fluticasone in bronchiectasis: A 12 months study. Thorax 2005;60:231.
15. * O'Donnell AE, et al. Treatment of idiopathic bronchiectasis with aerolized recombinant human DNase I. rhDNASE study. Chest 1998;113:1329.
16. Keistiner RT, et al. Bronchiectasis: An orphan disease with a poorly-understood prognosis. Europ Respir J 1997;10:2784.
17. King J, Bronchiectasis and COPD. COPD J 2005; 2:27-34.
18. Dupont M, et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 2004;125:1815.